mastijet forte suspensija ievadīšanai tesmenī
intervet international bv, nīderlande - tetracycline, neomycin, bacitracin, prednisolone - suspensija ievadīšanai tesmenī - laktējošas govis
prednisolonacetat-injektionssuspension 10 mg/ml suspensija injekcijām
as dimedium latvija, latvija - prednizolona acetāts - suspensija injekcijām - 10 mg/ml - kaķi; liellopi; suņi; zirgi
depo-medrone v 40 mg/ml suspensija injekcijām
zoetis belgium s.a., beļģija - metilprednizolona acetāts - suspensija injekcijām - 40 mg/ml - kaķi; suņi; zirgi
indigest injectable 100 mg/ml šķīdums injekcijām
laboratorios calier, s.a., spānija - menbutons - šķīdums injekcijām - 100 mg/ml - aitas; cūkas; kazas; liellopi; suņi; zirgi
depedin suspensija injekcijām
veyx-pharma gmbh, vācija - deksametazona, prednizolons acetāts - suspensija injekcijām - cūkas; kaķi; liellopi; sivēni; suņi; zirgi
abiraterone mylan
mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
adynovi
baxalta innovations gmbh - rurioktokogs alfa pegols - a hemofīlija - antihemorāģija - Ārstēšanas un profilakses asiņošanas pacientiem, 12 gadi un iepriekš ar hemofilijas (iedzimtas viii faktora deficīts).
raplixa
mallinckrodt pharmaceuticals ireland limited - cilvēka fibrinogēns, cilvēka trombīns - hemostāze, ķirurģija - antihemorāģija - atbalsta terapija, ja standarta ķirurģiskas metodes nav pietiekamas, lai uzlabotu hemostāzi. raplixa jālieto kopā ar apstiprinātu želatīns sūklis. raplixa ir norādīts pieaugušajiem, kas vecāki par 18 gadiem.
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - denges - vakcīnas - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.